FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154203739> ?p ?o ?g. }

• W3154203739 endingPage "110" @default.
• W3154203739 startingPage "102" @default.
• W3154203739 abstract "Natalizumab treatment provides a model for non-inflammation-induced disease progression in multiple sclerosis (MS).To study serum contactin-1 (sCNTN1) as a novel biomarker for disease progression in natalizumab-treated relapsing-remitting MS (RRMS) patients.Eighty-nine natalizumab-treated RRMS patients with minimum follow-up of 3 years were included. sCNTN1 was analyzed at baseline (before natalizumab initiation), 3, 12, 24 months (M) and last follow-up (median 5.2 years) and compared to 222 healthy controls (HC) and 15 primary progressive MS patients (PPMS). Results were compared between patients with progressive, stable, or improved disability according to EDSS-plus criteria.Median sCNTN1 levels (ng/mL,) in RRMS (baseline: 10.7, 3M: 9.7, 12M: 10.4, 24M: 10.8; last follow-up: 9.7) were significantly lower compared to HC (12.5; p ⩽ 0.001). It was observed that 48% of patients showed progression during follow-up, 11% improved, and 40% remained stable. sCNTN1 levels were significantly lower in progressors both at baseline and at 12M compared to non-progressors. A 1 ng/mL decrease in baseline sCNTN1 was consistent with an odds ratio of 1.23 (95% confidence interval 1.04-1.45) (p = 0.017) for progression during follow-up.Lower baseline sCNTN1 concentrations were associated with long-term disability progression during natalizumab treatment, making it a possible blood-based prognostic biomarker for RRMS." @default.
• W3154203739 created "2021-04-26" @default.
• W3154203739 creator A5015569020 @default.
• W3154203739 creator A5015967737 @default.
• W3154203739 creator A5020411307 @default.
• W3154203739 creator A5028904761 @default.
• W3154203739 creator A5041931606 @default.
• W3154203739 creator A5047046239 @default.
• W3154203739 creator A5049181172 @default.
• W3154203739 creator A5050514154 @default.
• W3154203739 creator A5054423408 @default.
• W3154203739 creator A5057441631 @default.
• W3154203739 creator A5064378373 @default.
• W3154203739 creator A5075394738 @default.
• W3154203739 creator A5078507054 @default.
• W3154203739 date "2021-04-23" @default.
• W3154203739 modified "2023-10-13" @default.
• W3154203739 title "Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis" @default.
• W3154203739 cites W1592361857 @default.
• W3154203739 cites W1789015615 @default.
• W3154203739 cites W1978838993 @default.
• W3154203739 cites W1984069677 @default.
• W3154203739 cites W1986333359 @default.
• W3154203739 cites W2025732446 @default.
• W3154203739 cites W2041388242 @default.
• W3154203739 cites W2051861976 @default.
• W3154203739 cites W2067184832 @default.
• W3154203739 cites W2068490031 @default.
• W3154203739 cites W2084842518 @default.
• W3154203739 cites W2089201356 @default.
• W3154203739 cites W2103758700 @default.
• W3154203739 cites W2104054393 @default.
• W3154203739 cites W2105206040 @default.
• W3154203739 cites W2136756445 @default.
• W3154203739 cites W2142577589 @default.
• W3154203739 cites W2159676982 @default.
• W3154203739 cites W2441939542 @default.
• W3154203739 cites W2489432788 @default.
• W3154203739 cites W2605302503 @default.
• W3154203739 cites W2750756186 @default.
• W3154203739 cites W2754967293 @default.
• W3154203739 cites W2808801810 @default.
• W3154203739 cites W2889214655 @default.
• W3154203739 cites W2903693539 @default.
• W3154203739 cites W2906456050 @default.
• W3154203739 cites W2910711926 @default.
• W3154203739 cites W2922528121 @default.
• W3154203739 cites W2947846735 @default.
• W3154203739 cites W3012517977 @default.
• W3154203739 cites W4211254511 @default.
• W3154203739 cites W4214677327 @default.
• W3154203739 cites W4226442578 @default.
• W3154203739 doi "https://doi.org/10.1177/13524585211010097" @default.
• W3154203739 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33890520" @default.
• W3154203739 hasPublicationYear "2021" @default.
• W3154203739 type Work @default.
• W3154203739 sameAs 3154203739 @default.
• W3154203739 citedByCount "13" @default.
• W3154203739 countsByYear W31542037392021 @default.
• W3154203739 countsByYear W31542037392022 @default.
• W3154203739 countsByYear W31542037392023 @default.
• W3154203739 crossrefType "journal-article" @default.
• W3154203739 hasAuthorship W3154203739A5015569020 @default.
• W3154203739 hasAuthorship W3154203739A5015967737 @default.
• W3154203739 hasAuthorship W3154203739A5020411307 @default.
• W3154203739 hasAuthorship W3154203739A5028904761 @default.
• W3154203739 hasAuthorship W3154203739A5041931606 @default.
• W3154203739 hasAuthorship W3154203739A5047046239 @default.
• W3154203739 hasAuthorship W3154203739A5049181172 @default.
• W3154203739 hasAuthorship W3154203739A5050514154 @default.
• W3154203739 hasAuthorship W3154203739A5054423408 @default.
• W3154203739 hasAuthorship W3154203739A5057441631 @default.
• W3154203739 hasAuthorship W3154203739A5064378373 @default.
• W3154203739 hasAuthorship W3154203739A5075394738 @default.
• W3154203739 hasAuthorship W3154203739A5078507054 @default.
• W3154203739 hasBestOaLocation W31542037391 @default.
• W3154203739 hasConcept C126322002 @default.
• W3154203739 hasConcept C143998085 @default.
• W3154203739 hasConcept C156957248 @default.
• W3154203739 hasConcept C185592680 @default.
• W3154203739 hasConcept C203014093 @default.
• W3154203739 hasConcept C2780640218 @default.
• W3154203739 hasConcept C2780892749 @default.
• W3154203739 hasConcept C2781004633 @default.
• W3154203739 hasConcept C2781197716 @default.
• W3154203739 hasConcept C44249647 @default.
• W3154203739 hasConcept C55493867 @default.
• W3154203739 hasConcept C71924100 @default.
• W3154203739 hasConcept C90924648 @default.
• W3154203739 hasConceptScore W3154203739C126322002 @default.
• W3154203739 hasConceptScore W3154203739C143998085 @default.
• W3154203739 hasConceptScore W3154203739C156957248 @default.
• W3154203739 hasConceptScore W3154203739C185592680 @default.
• W3154203739 hasConceptScore W3154203739C203014093 @default.
• W3154203739 hasConceptScore W3154203739C2780640218 @default.
• W3154203739 hasConceptScore W3154203739C2780892749 @default.
• W3154203739 hasConceptScore W3154203739C2781004633 @default.
• W3154203739 hasConceptScore W3154203739C2781197716 @default.

• next